More than 50 million adults over 18 have doctor-diagnosed arthritis, and one in two adults are affected by conditions and injuries affecting bones, joint and muscles in the feet.
Treatment options include anti-inflammatories, physical therapy and bracing to provide symptomatic relief. If these options don’t provide a long-lasting solution, surgery is often the next step. But, now there is a new, non-surgical, regenerative solution available.
AmnioFix(R), administered by injection, is a placental tissue allograft composed of the amnion and chorion layers of the amniotic sac. AmnioFix is not a stem cell treatment. It contains 285 different growth factors and regulatory proteins, which signal your body’s cells to go to the target site, help heal the site, plus help your own cells restore your damaged tissue. It is a new option to enhance healing, modulate inflammation and reduce scar tissue formation in many injuries or conditions.
Traditional methods, such as cortisone injections, have been used for many years to treat osteoarthritis and tendon injuries, and can have significant drawbacks including a degenerative effect over time. These traditional approaches have to be balanced with the realization that there is often long term damage to the structures being treated. AmnioFix has shown promise in the treatment of chronic tendon injuries and osteoarthritis, which are very challenging conditions to treat.
People who may be suffering from sports-related foot injuries or arthritis should consult their orthopedist or foot Doctor to determine the best treatment plan.

Contact our offices Laurel Foot & Ankle Center or Northern Virginia Foot & Ankle Associates  and schedule an appointment today.
To learn more about AmnioFix treatment, go to Heel Pain Institute of America and Laurel Foot & Ankle Center or Northern Virginia Foot & Ankle Associates.